Company Overview
Company Type: Public Company
Website: www.achievelifesciences.com
Number of Employees: 20
Ticker: ACHV (NasdaqCM)
Year Founded: -


Business Description
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.

Financial Information (Currency: CAD, in mm) 
Market Capitalization
118.0
EBITDA
(54.3)
Total Enterprise Value
105.3
TEV/EBITDA
NM
EBIT
(54.7)
Cash & ST Invst.
34.4
P/Diluted EPS Before Extra
NM
Net Income
(57.1)
Total Debt
21.7
Price/Tang BV
11.7x
Total Assets
39.7
Total Debt/EBITDA
NM
Currency in CAD in mm, LTM as of Jun-30-2023 TEV and Market Cap are calculated using a close price as of Oct-04-2023


Estimates Snapshot (Current Fiscal Year End: Dec-31-2023 | Currency: CAD)
Periodic Estimates
Current FQ
Current FQ+1
Current FY
Current FY+1
NTM
EPS (GAAP)
(0.52)
(0.53)
(2.31)
(2.24)
(2.21)
Revenue (mm)
0.00
0.00
0.00
0.00
0.00

Forward Multiples (Current FY)

Price/Earnings
NM

Non-Periodic Estimates

Recommendation
Buy (1.00)
Target Price
41.21
Potential Upside
650.00%


Key Professionals
Name
Title
Stewart, Richard A. B.
Executive Chairman
Bencich, John A.
CEO & Director
Jacobs, Cindy 
President, Chief Medical Officer & Director
Wan, Jerry 
Principal Accounting Officer
Clarke, Anthony 
Chief Scientific Officer
Xinos, Jaime 
Executive Vice President of Commercial

Key Board Members
Name
Title
Stewart, Richard A. B.
Executive Chairman
Bencich, John A.
CEO & Director
Jacobs, Cindy 
President, Chief Medical Officer & Director
Duty, Stuart 
Director
King, Thomas B.
Director
Martell, Bridget Ann
Independent Director
Himes, Vaughn B.
Independent Director
Sellig, Thomas 
Director


Primary Industry Classification
Biotechnology


Primary Office Location
1040 West Georgia Street Suite 1030 | Vancouver, BC | V6E 4H1 | Canada
Phone: 604 210 2217   

Current and Pending Investors
Adamas Fund, LLC, Anson Group, Armistice Capital LLC, Chitayat Holdings LLC, Compass Investments, Inc., CVI Investments, Inc., Dialectic Capital Management, LP, First-Citizens Bank & Trust Company, Inc. (Pending), Hudson Bay Capital Management LP, Iroquois Capital Management, LLC, Lincoln Park Capital, LLC, MIS Partners, LLC, Paulson Investment Company, LLC, Pranabio Investments, Llc, Pura Vida Investments, LLC, Rosalind Advisors, Inc., Silicon Valley BancVentures, Inc., Sio Capital Management, LLC, Velcro, LLC, Walleye Trading LLC

Prior Investors
AIGH Investment Partners, Silicon Valley Bank

Stock Quote and Chart (Currency: CAD)
Last  (Delayed)
 5.50
Market Cap (mm)
116.0
Open
 5.59
Shares Out. (mm)
21.1
Previous Close
 5.50
Float %
98.9%
Change on Day
(0.10)
Shares Sold Short (mm)
0.7
Change % on Day
(1.7)%
Dividend Yield %
-
Day High/Low
 5.62/ 5.50
Diluted EPS Excl. Extra Items
(3.79)
52 wk High/Low
 14.15/ 2.75
P/Diluted EPS Before Extra
NM
Volume (mm)
0.03
Avg 3M Dly Vlm (mm)
0.05
Beta 5Y
1.44


 
Delayed Quote** | Last Updated on Oct-05-2023 12:00 AM (GMT-5)
NasdaqCM:ACHV - Common Stock


Index Membership
S&P Completion Index (CI);S&P TMI Index;S&P Americas Under USD3 Billion Index;S&P Americas BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Americas Under USD2 Billion Index;S&P Americas BMI Growth Index;S&P Americas BMI Value Index;S&P Americas SmallCap Health Care (Sector) Index;S&P Americas Under USD1 Billion Index;S&P Americas BMI Index;S&P Americas BMI Health Care (Sector) Index;S&P Americas SmallCap Index;S&P Developed BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Americas Under USD1.2 Billion Index;S&P Americas SmallCap Growth Index;S&P Americas Under USD1.5 Billion Index;S&P Americas SmallCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Americas SmallCap Value Index;S&P DM Ex-Australia SmallCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed BMI Value Index;S&P Developed Ex-Asia-Pacific BMI Growth Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific BMI Value Health Care (Sector) Index;S&P Developed Ex-Australia Under USD1 Billion Index;S&P Developed Ex-Australia Under USD1.2 Billion Index;S&P Developed Ex-Canada SmallCap Value Health Care (Sector) Index;S&P Developed Ex-Canada Under USD1.5 Billion Index;S&P Developed Ex-Europe BMI Growth Index;S&P Developed Ex-Europe BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Europe SmallCap Health Care (Sector) Index;S&P Developed BMI Index;S&P Developed Ex-Asia-Pacific BMI Growth Index;S&P Developed Ex-Australia BMI Index;S&P Developed Ex-Eurozone BMI Growth Index;S&P Developed Ex-Eurozone SmallCap Index;S&P Developed Ex-Eurozone SmallCap Health Care (Sector) Index;S&P Developed BMI Growth Index;S&P Developed Ex-Asia-Pacific BMI Index;S&P DM Ex-Asia-Pacific BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Asia-Pacific BMI Value Index;S&P Developed Ex-Australia SmallCap Growth Health Care (Sector) Index;S&P Developed Ex-Australia Under USD3 Billion Index;S&P Developed Ex-Europe BMI Growth Health Care (Sector) Index;S&P Developed Ex-Australia SmallCap Growth Index;S&P Developed Ex-Canada BMI Index;S&P Developed Ex-Canada BMI Health Care (Sector) Index;S&P Developed Ex-Canada BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Canada SmallCap Growth Health Care (Sector) Index;S&P Developed Ex-Switzerland BMI Index;S&P Developed Ex-Switzerland SmallCap Health Care (Sector) Index;S&P Developed Ex-Switzerland SmallCap Pharma., biotech. & Life Sci. (Industry Group) Index;S&P Developed Ex-Switzerland Under USD1 Billion Index;S&P Developed Ex-Switzerland Under USD3 Billion Index;S&P Developed Ex-U.K. BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Asia-Pacific SmallCap Growth Index;S&P Developed Ex-Asia-Pacific SmallCap Growth Health Care (Sector) Index;S&P Developed Ex-Eurozone BMI Index;S&P Developed Ex-Eurozone SmallCap Value Index;S&P Developed Ex-Eurozone Under USD1.5 Billion Index;S&P Developed Ex-Japan BMI Index;S&P Developed Ex-Japan BMI Growth Health Care (Sector) Index;S&P Developed Ex-Japan BMI Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific Under USD2 Billion Index;S&P Developed Ex-Australia BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Australia SmallCap Value Index;S&P Developed Ex-Japan SmallCap Growth Health Care (Sector) Index;S&P Developed Ex-Japan Under USD2 Billion Index;S&P Developed Ex-Switzerland BMI Health Care (Sector) Index;S&P Developed Ex-Switzerland SmallCap Growth Health Care (Sector) Index;S&P Developed Ex-Switzerland SmallCap Value Health Care (Sector) Index;S&P Developed Ex-Switzerland Under USD2 Billion Index;S&P Developed Ex-Europe SmallCap Index;S&P Developed Ex-Europe Under USD1 Billion Index;S&P Developed Ex-Europe Under USD1.5 Billion Index;S&P Developed Ex-Eurozone BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Eurozone Under USD1 Billion Index;S&P Developed Ex-Asia-Pacific Under USD1.2 Billion Index;S&P Developed Ex-Asia-Pacific Under USD3 Billion Index;S&P Developed Ex-Australia BMI Growth Index;S&P Developed Ex-Australia BMI Growth Health Care (Sector) Index;S&P Developed Ex-Australia BMI Health Care (Sector) Index;S&P Developed Ex-Canada BMI Growth Health Care (Sector) Index;S&P Developed Ex-Japan BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Japan Under USD1 Billion Index;S&P Developed Ex-Japan Under USD1.2 Billion Index;S&P Developed Ex-U.K. BMI Growth Health Care (Sector) Index;S&P Developed Ex-U.K. BMI Health Care (Sector) Index;S&P Developed Ex-U.K. Under USD1 Billion Index;S&P Developed Ex-U.K. Under USD1.2 Billion Index;S&P Developed Ex-Canada SmallCap Health Care (Sector) Index;S&P Developed Ex-Canada Under USD2 Billion Index;S&P Developed Ex-Europe SmallCap Value Health Care (Sector) Index;S&P Developed Ex-Eurozone BMI Value Health Care (Sector) Index;S&P Developed SmallCap Value Health Care (Sector) Index;S&P Developed Under USD1.2 Billion Index;S&P Developed Under USD3 Billion Index;S&P Developed SmallCap Index;S&P Developed Ex-Eurozone SmallCap Growth Index;S&P DM Ex-Eurozone SmallCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Japan SmallCap Health Care (Sector) Index;S&P DM Ex-Japan SmallCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Canada BMI Growth Index;S&P Developed Ex-Canada BMI Value Health Care (Sector) Index;S&P DM Ex-Canada SmallCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Canada SmallCap Value Index;S&P Developed Ex-Europe BMI Index;S&P Developed Ex-U.K. BMI Value Health Care (Sector) Index;S&P Developed Ex-U.K. SmallCap Index;S&P Developed Ex-U.K. SmallCap Value Index;S&P Developed Ex-U.K. Under USD1.5 Billion Index;S&P Developed Ex-U.K. BMI Growth Index;S&P Developed Ex-U.K. BMI Value Index;S&P Developed Ex-U.K. SmallCap Health Care (Sector) Index;S&P Developed BMI Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific SmallCap Pharma., biotech. & Life Sci. (Industry Group) Index;S&P Developed Ex-Australia BMI Value Health Care (Sector) Index;S&P Developed Ex-Europe SmallCap Growth Index;S&P Developed Ex-Europe Under USD1.2 Billion Index;S&P Developed Ex-Eurozone BMI Growth Health Care (Sector) Index;S&P Developed Ex-Eurozone Under USD1.2 Billion Index;S&P Developed Ex-Eurozone Under USD2 Billion Index;S&P Developed Ex-Eurozone Under USD3 Billion Index;S&P Developed Ex-Japan BMI Value Health Care (Sector) Index;S&P Developed Ex-Australia SmallCap Health Care (Sector) Index;S&P Developed Ex-Canada Under USD1.2 Billion Index;S&P Developed Ex-Canada Under USD3 Billion Index;S&P Global BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Global Ex-Pan Asia BMI Health Care (Sector) Index;S&P Global Ex-Pan Asia BMI Value Index;S&P Global Ex-Pan Asia SmallCap Pharmaceuticals, Biotech & Life Sciences (Industry Group) Index;S&P Developed Ex-Europe BMI Value Index;S&P Developed Ex-Europe SmallCap Growth Health Care (Sector) Index;S&P Developed Ex-Europe Under USD2 Billion Index;S&P Developed Ex-Europe Under USD3 Billion Index;S&P Developed Ex-Eurozone BMI Value Index;S&P Developed Ex-Japan SmallCap Index;S&P Developed Ex-Switzerland BMI Growth Index;S&P Developed Ex-Switzerland BMI Growth Health Care (Sector) Index;S&P DM Ex-Switzerland BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Switzerland BMI Value Index;S&P Developed Under USD1.5 Billion Index;S&P Developed Ex-Japan SmallCap Growth Index;S&P Developed Ex-Japan SmallCap Value Index;S&P Developed Ex-Switzerland SmallCap Index;S&P Developed Ex-Switzerland SmallCap Growth Index;S&P Developed Ex-Switzerland Under USD1.5 Billion Index;S&P Developed Ex-U.K. SmallCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-U.K. SmallCap Value Health Care (Sector) Index;S&P Developed Ex-U.K. Under USD2 Billion Index;S&P Developed Ex-U.K. Under USD3 Billion Index;S&P Developed BMI Growth Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific SmallCap Index;S&P Developed Ex-Asia-Pacific SmallCap Value Index;S&P Developed Ex-Asia-Pacific SmallCap Value Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific Under USD1 Billion Index;S&P Developed Ex-Australia BMI Value Index;S&P Developed Ex-U.K. SmallCap Growth Health Care (Sector) Index;S&P Developed Ex-Australia SmallCap Index;S&P Developed Ex-Canada BMI Value Index;S&P Developed Ex-Canada SmallCap Index;S&P Developed Ex-Canada Under USD1 Billion Index;S&P Developed Ex-Europe BMI Health Care (Sector) Index;S&P Developed Ex-Europe BMI Value Health Care (Sector) Index;S&P Developed Ex-Eurozone BMI Health Care (Sector) Index;S&P Global Ex-Japan Under USD1.5 Billion Index;S&P Global Ex-Japan Under USD2 Billion Index;S&P Global Ex-Pan Asia BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Japan Under USD3 Billion Index;S&P Developed Ex-Switzerland Under USD1.2 Billion Index;S&P Developed Ex-U.K. BMI Index;S&P Global Ex-Japan BMI Value Index;S&P Global BMI Index;S&P Global Ex-Japan Under USD3 Billion Index;S&P Global Ex-Japan BMI Health Care (Sector) Index;S&P Global Ex-Pan Asia SmallCap Growth Index;S&P Global SmallCap Health Care (Sector) Index;S&P Developed Under USD2 Billion Index;S&P Global Under USD2 Billion Index;S&P Global Under USD3 Billion Index;S&P Global SmallCap Index;S&P Global SmallCap Growth Index;S&P North America BMI Value Health Care (Sector) Index;S&P North America SmallCap Index;S&P North America SmallCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Global Ex-Japan SmallCap Index;S&P Global Ex-Japan Under USD1 Billion Index;S&P Global Ex-Japan Under USD1.2 Billion Index;S&P Global Ex-Pan Asia SmallCap Health Care (Sector) Index;S&P Global Ex-Pan Asia SmallCap Value Index;S&P Global Ex-Pan Asia Under USD1 Billion Index;S&P Global Ex-Pan Asia Under USD1.5 Billion Index;S&P North America BMI Index;S&P Global SmallCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P North America SmallCap Value Index;S&P Global Ex-Japan SmallCap Value Index;S&P Global Ex-Pan Asia Under USD1.2 Billion Index;S&P Global Ex-Pan Asia Under USD2 Billion Index;S&P Global Ex-Pan Asia Under USD3 Billion Index;S&P United States BMI Index;S&P Global Under USD1 Billion Index;S&P Global Under USD1.5 Billion Index;S&P United States SmallCap Value Health Care (Sector) Index;S&P United States Under USD1.2 Billion Index;S&P United States BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P United States Under USD1.5 Billion Index;S&P North America SmallCap Growth Health Care (Sector) Index;S&P North America BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P North America BMI Value Index;S&P North America SmallCap Health Care (Sector) Index;S&P North America Under USD1.2 Billion Index;S&P North America Under USD1.5 Billion Index;S&P Developed SmallCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Under USD1 Billion Index;S&P North America Under USD2 Billion Index;S&P North America Under USD3 Billion Index;S&P Global BMI Growth Index;S&P United States BMI Growth Health Care (Sector) Index;S&P United States BMI Health Care (Sector) Index;S&P United States SmallCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P United States SmallCap Value Index;S&P United States Under USD2 Billion Index;S&P United States BMI Value Health Care (Sector) Index;S&P United States Under USD1 Billion Index;S&P Global Ex-Japan BMI Growth Index;S&P Global Ex-Japan BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Global Ex-Japan SmallCap Growth Index;S&P Global Ex-Pan Asia BMI Index;S&P Global Ex-Pan Asia BMI Growth Index;S&P United States BMI Growth Index;S&P United States SmallCap Growth Index;S&P United States Under USD3 Billion Index;S&P North America BMI Growth Index;S&P North America BMI Growth Health Care (Sector) Index;S&P North America BMI Health Care (Sector) Index;S&P North America SmallCap Value Health Care (Sector) Index;S&P United States BMI Value Index;S&P United States SmallCap Growth Health Care (Sector) Index;S&P United States SmallCap Health Care (Sector) Index;S&P Developed BMI Value Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific BMI Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific SmallCap Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific Under USD1.5 Billion Index;S&P Developed Ex-Australia SmallCap Value Health Care (Sector) Index;S&P Developed Ex-Australia Under USD1.5 Billion Index;S&P Developed Ex-Australia Under USD2 Billion Index;S&P Developed Ex-Canada SmallCap Growth Index;S&P DM Ex-Europe SmallCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Europe SmallCap Value Index;S&P Developed Ex-Eurozone SmallCap Growth Health Care (Sector) Index;S&P Developed Ex-Eurozone SmallCap Value Health Care (Sector) Index;S&P Developed Ex-Japan BMI Growth Index;S&P Developed Ex-Japan BMI Value Index;S&P Developed Ex-Japan SmallCap Value Health Care (Sector) Index;S&P Developed Ex-Japan Under USD1.5 Billion Index;S&P Developed Ex-Switzerland BMI Value Health Care (Sector) Index;S&P Developed Ex-Switzerland SmallCap Value Index;S&P Developed Ex-U.K. SmallCap Growth Index;S&P Developed SmallCap Growth Index;S&P Developed SmallCap Growth Health Care (Sector) Index;S&P Developed SmallCap Health Care (Sector) Index;S&P Developed SmallCap Value Index;S&P Global BMI Health Care (Sector) Index;S&P Global BMI Value Index;S&P Global Ex-Japan BMI Index;S&P Global Ex-Japan SmallCap Health Care (Sector) Index;S&P Global Ex-Japan SmallCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Global Ex-Pan Asia SmallCap Index;S&P Global SmallCap Value Index;S&P Global Under USD1.2 Billion Index;S&P North America SmallCap Growth Index;S&P North America Under USD1 Billion Index;S&P United States SmallCap Index;S&P Developed Ex-Japan BMI Growth Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Eurozone BMI Growth Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P United States BMI Growth Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P North America BMI Growth Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Canada BMI Growth Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Asia Pacific BMI Growth Pharm, Biotech & Life Sciences (Industry Group) Index;S&P Developed Ex-Switzerland BMI Growth Pharm, Biotech & Life Sciences (Industry Group) Index;S&P Developed Ex-Europe BMI Growth Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-UK BMI Growth Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Australia BMI Growth Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Eurozone BMI Value Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Asia Pacific BMI Value Pharm, Biotech & Life Sciences (Industry Group) Index;S&P Developed Ex-Australia BMI Value Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Switzerland BMI Value Pharm, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-UK BMI Value Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Europe BMI Value Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Canada BMI Value Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P United States BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group)  Index;S&P North America BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group)  Index;S&P Developed Ex-Japan BMI Value Pharm, Biotechnology & Life Sciences (Industry Group)  Index;S&P Completion Index (CI) Health Care (US Dollar);S&P TMI Health Care;S&P Developed Ex-Israel BMI Growth Index;S&P Developed Ex-Israel BMI Growth Health Care (Sector) Index;S&P Developed Ex-Israel BMI Index;S&P Developed Ex-Israel BMI Health Care (Sector) Index;S&P Developed Ex-Israel BMI Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Israel BMI Value Index;S&P Developed Ex-Israel BMI Value Health Care (Sector) Index;S&P Developed Ex-Israel SmallCap Growth Index;S&P Developed Ex-Israel SmallCap Growth Health Care (Sector) Index;S&P Developed Ex-Israel SmallCap Index;S&P Developed Ex-Israel SmallCap Health Care (Sector) Index;S&P DM Ex-Israel SmallCap Pharmaceuticals, Biotechnology & Life Sciences (Industry Group) Index;S&P Developed Ex-Israel SmallCap Value Index;S&P Developed Ex-Israel SmallCap Value Health Care (Sector) Index;S&P Developed Ex-Israel Under USD1 Billion Index;S&P Developed Ex-Israel Under USD1.2 Billion Index;S&P Developed Ex-Israel Under USD1.5 Billion Index;S&P Developed Ex-Israel Under USD2 Billion Index;S&P Developed Ex-Israel Under USD3 Billion Index;S&P Global Ex-Australia BMI Index;S&P Global Ex-Europe BMI Index;S&P Global Ex-United Kingdom BMI Index;S&P Developed Ex-Continental Europe BMI Index;S&P Developed Ex-Japan, Ex-South Korea BMI Index;S&P DM Ex. Japan SmallCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P DM Ex. Japan SmallCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P DM Ex-Australia SmallCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group;S&P DM Ex-Israel SmallCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Switzerland SmallCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Subsect;S&P Developed Ex-U.K. SmallCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Asia-Pacific SmallCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Subsec;S&P DM Ex-Australia SmallCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Asia-Pacific SmallCap Value Pharmaceuticals, Biotechnology & Life Sciences (Subsect;S&P DM Ex-Canada SmallCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P DM Ex-Europe SmallCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P DM Ex-Eurozone SmallCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P DM Ex-Eurozone SmallCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Israel BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Israel BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P DM Ex-Canada SmallCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P DM Ex-Israel SmallCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed SmallCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed SmallCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Switzerland SmallCap Value Pharmaceuticals, Biotechnology & Life Sciences (Subsecto;S&P North America SmallCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P DM Ex-U.K. SmallCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P DM Ex-Europe SmallCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P North America SmallCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P United States SmallCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P United States SmallCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Global Ex-China A BMI;S&P Global Ex-China A SmallCap;S&P Developed Ex-Korea BMI;S&P Developed Ex-Korea SmallCap;S&P Developed BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Asia Pacific BMI Val Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Japan SmallCap Val Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Switzerland BMI Grwth Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Canada BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Canada BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Australia BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Asia Pacific SmallCap Val Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Australia SmallCap Growth Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Canada SmallCap Val Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Eurozone BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Europe BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Europe BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-UK SmallCap Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Israel SmallCap Val Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Switzerland SmallCap Val Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Europe SmallCap Val Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Eurozone BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Eurozone SmallCap Val Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Japan SmallCap Grwth Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Israel SmallCap Grwth Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Australia BMI Grwth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Canada SmallCap Grwth Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Europe SmallCap Grwth Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-UK BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P North America BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-UK BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-UK SmallCap Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Japan BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P United States BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Asia Pacific BMI Grwth Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Asia Pacific SmallCap Grwth Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Australia SmallCap Val Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Eurozone SmallCap Grwth Pharma, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Japan BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Switzerland BMI Val Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Switzerland SmallCap Grwth Pharma, Biotechnology & Life Sciences (Industry Group);S&P United States BMI Growth Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P North America BMI Value Pharmaceuticals, Biotechnology & Life Sciences (Industry Group);S&P Developed Ex-Korea BMI Growth;S&P Developed Ex-Korea BMI Value


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Current and Pending Subsidiaries / Investments
Company Name
Business Description
Geography
Primary Industry
LTM Total Rev.($mm)
LFQ Total Assets ($mm)
LFQ Total Debt ($mm)
OncoGenex Pharmaceuticals, Inc.
As of August 1, 2017, OncoGenex Pharmaceuticals, Inc. was acquired by Achieve Life Science, Inc., in a reverse merger transaction. OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.

United States and Canada
Biotechnology
0.00
15.00
0.00
Achieve Life Sciences Technologies Inc
Achieve Life Sciences Technologies Inc operates as a subsidiary of Achieve Life Sciences, Inc.

United States and Canada
-
-
-
-
OncoGenex Technologies Inc.

United States and Canada
-
-
-
-


Last 5 Transactions
Announced Date
Closed Date
Transaction Type
Role
Target
Buyer/Investors
Sellers
Size($mm)
Jun-14-2023
-
Shelf Registration
Target
Achieve Life Sciences, Inc. (NasdaqCM:ACHV)


11.88
May-25-2023
-
Public Offering
Target
Achieve Life Sciences, Inc. (NasdaqCM:ACHV)


16.50
Mar-16-2023
-
Shelf Registration
Target
Achieve Life Sciences, Inc. (NasdaqCM:ACHV)


5.15
Dec-29-2022
Jan-9-2023
Shelf Registration
Target
Achieve Life Sciences, Inc. (NasdaqCM:ACHV)


34.38
Nov-14-2022
-
Private Placement
Target
Achieve Life Sciences, Inc. (NasdaqCM:ACHV)


25.00
* denotes that the relationship is proprietary


Last 5 Key Developments
Date
Event Type
Headline
Sep-28-2023
Company Conference Presentations
Achieve Life Sciences, Inc. Presents at Cantor Fitzgerald Annual Global Healthcare Conference 2023, Sep-28-2023 08:00 AM
Sep-18-2023
Index Constituent Adds
Achieve Life Sciences, Inc.(NasdaqCM:ACHV) added to S&P Global BMI Index
Sep-14-2023
Company Conference Presentations
Achieve Life Sciences, Inc. Presents at Lake Street Capital Markets 7th Annual Best Ideas Growth Conference, Sep-14-2023
Sep-11-2023
Product-Related Announcements
Achieve Life Sciences, Inc. Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting
Sep-11-2023
Company Conference Presentations
Achieve Life Sciences, Inc. Presents at H.C. Wainwright 25th Annual Global Investment Conference, Sep-11-2023 07:00 AM

M&A Advisors
Paul Hastings LLP


Advisors
Most Recent Auditor
PricewaterhouseCoopers LLP
M&A Advisors
Paul Hastings LLP
Private Placement Advisors
Fenwick & West LLP, Lake Street Capital Markets, LLC
Public Offering Advisors
Fenwick & West LLP, Ladenburg Thalmann & Co. Inc., Lake Street Capital Markets, LLC, PricewaterhouseCoopers LLP, Tigress Financial Partners, LLC


Most Recent Auditor
PricewaterhouseCoopers LLP


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
S&P Global Compustat

03:29 AM
ACHV
Achieve Life Sciences Inc 2023_10_05
Reports
14
ValuEngine, Inc.

Oct 02, 2023 02:43 AM
ACHV
ValuEngine Rating and Forecast Report for ACHV
Reports
11
The Economy Matters

Oct 02, 2023 01:33 AM
ACHV
The Economy Matters
Reports
8
CFRA Equity Research

Oct 01, 2023 08:19 AM
ACHV
Achieve Life Sciences, Inc.
Reports
9
Lake Street Capital Markets, LLC
Flaten, Thomas
Sep 18, 2023 05:27 AM
ACHV
BIG7 Conference Recap: Our Thoughts From Lake Street’s BIG7 Conference
Notes
4
Ladenburg Thalmann & Company
Higgins, Michael John
Sep 14, 2023 11:12 AM
ACHV
ORCA-V1 New Data; Cytisinicline Shows Efficacy at 16 Weeks; Reiterate Buy, $35 PT
Initiation of Coverage*
35
GlobalData

Sep 13, 2023 03:23 AM
ACHV
Achieve Life Sciences Inc (ACHV.NASD) - Financial Analysis Review
Reports
424
S&P Global Compustat

Sep 07, 2023 03:14 AM
ACHV
Achieve Life Sciences Inc 2023_09_07
Reports
14
CG Capital
CG Capital Research Team
Aug 17, 2023 06:56 AM
ACHV
ACHV: 2Q Review: NDA Moving Forward…Partner or Buy?; Reiterate OUTPERFORM Rating & $20 PT
Reporting Results*
4
Zacks Small-Cap Research
Vandermosten, John D.
Aug 16, 2023 11:02 AM
ACHV
ACHV: 2Q:23 Results
Reports
8


Ownership Summary

            Top Holders 
Holders by Type
Holder

Common Stock Equivalent Held

% of Total Shares Outstanding

Market Value (CAD in mm)

Position Date


B. Riley Capital Management, LLC

3,494,000

16.55

20.6

Apr-18-2023


Contrarian Alpha Management, LLC

1,438,918

6.82

8.5

May-25-2023


Shay Capital LLC

776,600

3.68

4.6

Jun-30-2023


The Vanguard Group, Inc.

577,793

2.74

3.4

Jun-30-2023


Francis Capital Management, LLC

432,432

2.05

2.6

Dec-31-2022


AWM Investment Company Inc

272,500

1.29

1.6

Jun-30-2023


Long Focus Capital Management LLC

248,099

1.18

1.5

Jun-30-2023


B. Riley Wealth Advisors, Inc.

216,216

1.02

1.3

Jun-30-2023


Geode Capital Management, LLC

162,288

0.77

1.0

Jun-30-2023


LPL Financial Corporation, Asset Management Arm

148,000

0.70

0.9

Jun-30-2023



 



Top Buyers
Buyers
Common Stock Equivalent Held
Change
Shay Capital LLC
776,600
296,600
AWM Investment Company Inc
272,500
272,500
B. Riley Wealth Advisors, Inc.
216,216
216,216
The Vanguard Group, Inc.
577,793
158,409
One68 Global Capital, LLC
96,700
96,700

Top Sellers
Sellers
Common Stock Equivalent Held
Change
Heights Capital Management, Inc.
11,200
(215,924)
Ikarian Capital, LLC
0
(174,714)
Group One Trading LP, Asset Management Arm
13,606
(123,640)
Long Focus Capital Management LLC
248,099
(65,121)
Next Edge Capital Corp.
0
(25,000)


S&P Global Ratings Credit Ratings
No S&P Global Ratings Credit Ratings data available. 


News Headlines
Date/Time
Headline
Source
Sep-12
EFFECTOR THERAPEUTICS APPOINTS CAROLINE LOEWY TO BOARD OF DIRECTORS
ENP Newswire
Sep-11
Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting
GlobeNewswire


Company Coverage
This company is not on any Coverage List.

Products
Cytisinicline (Future)


Upcoming Events
Date/Time
Type
Oct-09-2023
Company Conference Presentations
Oct-09-2023
Conferences
Oct-12-2023
Conferences
* Future Events are subject to change.


Recent Major Filings

Key Filings
Filed On
Period Date
Company Name
Source
Form Type
Size
Aug-14-2023
Jun-30-2023
Achieve Life Sciences, Inc. (NasdaqCM:ACHV)
SEDAR
Interim Financial Statements
780 KB
Aug-14-2023
-
Achieve Life Sciences, Inc. (NasdaqCM:ACHV)
SEDAR
News Releases
267 KB
Aug-14-2023
Jun-30-2023
Achieve Life Sciences, Inc. (NasdaqCM:ACHV)
SEC
10-Q
9 MB
Aug-14-2023
Aug-14-2023
Achieve Life Sciences, Inc. (NasdaqCM:ACHV)
SEC
8-K (2.02, 9.01)
562 KB
Jun-14-2023
-
Achieve Life Sciences, Inc. (NasdaqCM:ACHV)
SEC
S-3
236 KB
Jun-09-2023
Jun-07-2023
Achieve Life Sciences, Inc. (NasdaqCM:ACHV)
SEC
8-K (5.03, 5.07, 9.01)
238 KB
May-25-2023
-
Achieve Life Sciences, Inc. (NasdaqCM:ACHV)
SEC
424B5
565 KB
May-25-2023
May-25-2023
Achieve Life Sciences, Inc. (NasdaqCM:ACHV)
SEC
8-K (1.01, 7.01, 9.01)
711 KB
May-23-2023
May-23-2023
Achieve Life Sciences, Inc. (NasdaqCM:ACHV)
SEC
8-K (7.01, 8.01, 9.01)
10 MB
May-17-2023
May-15-2023
Achieve Life Sciences, Inc. (NasdaqCM:ACHV)
SEC
8-K (1.01, 2.03, 9.01)
2 MB


Insider Trades
Holder Name
Trade Date Range
Security Type
Transacted Shares
Transaction Value Range (CAD)
Transaction Type
% Change
Source
Bencich M.B.A., John A. (CEO & Director)
May-30-2023
Common Stock
5,000
37,778
Private Acquisition
8.10
Form 4
Jacobs M.D., Ph.D., Cindy  (President, Chief Medical Officer & Director)
Apr-28-2023
Common Stock
(609)
(6,936)
Derivative Exercise and Sale
-
Form 4
-
Apr-28-2023
Common Stock
609
0
Derivative Exercise
-
Form 4
-
Apr-28-2023
Common Stock
(609)
(6,936)
Sale
-
Form 4
Jacobs M.D., Ph.D., Cindy  (President, Chief Medical Officer & Director)
Apr-28-2023
Common Stock
1,891
0
Derivative Exercise and Retained Stock
11.55
Form 4
Stewart, Richard A. B. (Executive Chairman)
Apr-28-2023
Common Stock
2,750
0
Derivative Exercise and Retained Stock
10.53
Form 4
Stewart, Richard A. B. (Executive Chairman)
Apr-28-2023
Common Stock
(2,250)
(25,624)
Derivative Exercise and Sale
-
Form 4
-
Apr-28-2023
Common Stock
2,250
0
Derivative Exercise
-
Form 4
-
Apr-28-2023
Common Stock
(2,250)
(25,624)
Sale
-
Form 4
Excluding Automatic Transactions
Key Board Members Details
Name
Title
Phone
Fax
Email
Stewart, Richard A. B.
Executive Chairman
(604) 736-3678
-

Bencich, John A.
CEO & Director
(604) 210-2217
-

Jacobs, Cindy 
President, Chief Medical Officer & Director
604 210 2217
-

Duty, Stuart 
Director
604 210 2217
-

King, Thomas B.
Director
604 210 2217
-
tking@alexza.com
Martell, Bridget Ann
Independent Director
604 210 2217
-

Himes, Vaughn B.
Independent Director
604 210 2217
-

Sellig, Thomas 
Director
604 210 2217
-

* denotes that the relationship is proprietary

Key Executives and Professionals Details
Name
Title
Phone
Fax
Email
Stewart, Richard A. B.
Executive Chairman
(604) 736-3678
-

Bencich, John A.
CEO & Director
(604) 210-2217
-

Jacobs, Cindy 
President, Chief Medical Officer & Director
604 210 2217
-

Wan, Jerry 
Principal Accounting Officer
604 210 2217
-

Clarke, Anthony 
Chief Scientific Officer
604 210 2217
-

Xinos, Jaime 
Executive Vice President of Commercial
604 210 2217
-
-
* denotes that the relationship is proprietary

Historical Equity Pricing Data supplied by Interactive Data Pricing and Reference Data LLC 
S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 

**Intraday Quotes are delayed by at least 20 minutes.
